Abbott Laboratories (ABT) Cash & Equivalents (2009 - 2026)
Abbott Laboratories' Cash & Equivalents was $5.1 billion in Q2 2026, down 26.6% from $6.95 billion a year earlier and down 25.0% from the prior quarter.
Abbott Laboratories (ABT) Cash & Equivalents (2009 - 2026) Analysis & Trends
At the end of FY2025, Cash & Equivalents at Abbott Laboratories came in at $8.52 billion, up 11.9% from FY2024.
- Cash & Equivalents shows a five-year compound annual growth rate of 4.5% (FY2020 to FY2025).
- In earlier years, Cash & Equivalents was $7.62 billion in FY2024 (+10.4%), $6.9 billion in FY2023 (-30.2%), $9.88 billion in FY2022 (+0.8%) and $9.8 billion in FY2021 (+43.3%).
- The Q2 2026 figure marks the lowest quarterly Cash & Equivalents since Q3 2020.
- Compared with a year earlier, Cash & Equivalents was higher in five of the last eight quarters, with growth averaging 1.9%.
- The best year-over-year quarter for Cash & Equivalents over five years was Q3 2021 (growth of 107.6%); the worst was Q1 2024 (a decline of 31.4%).
- Per Business Quant data, ABT's Cash & Equivalents in the three quarters before Q2 2026 was $6.8 billion (Q1 2026), $8.52 billion (Q4 2025) and $7.51 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.25 Bn | 220.40 Bn | 4.88 Bn | 4.06 Bn |
| 2 | Abbott Laboratories | 167.33 Bn | 138.41 Bn | 7.27 Bn | 5.10 Bn |
| 3 | Danaher | 148.83 Bn | 132.65 Bn | 3.61 Bn | 4.35 Bn |
| 4 | Intuitive Surgical | 142.00 Bn | 121.55 Bn | 1.96 Bn | 2.76 Bn |
| 5 | Medtronic | 110.70 Bn | 76.57 Bn | 6.34 Bn | 1.69 Bn |
| 6 | Stryker | 104.72 Bn | 90.84 Bn | 4.50 Bn | 3.39 Bn |
| 7 | Boston Scientific | 62.66 Bn | 57.67 Bn | 3.85 Bn | 539.00 Mn |
| 8 | Edwards Lifesciences | 49.13 Bn | 33.24 Bn | 1.35 Bn | 2.91 Bn |
| 9 | Becton Dickinson | 48.51 Bn | 45.66 Bn | 2.32 Bn | 708.00 Mn |
| 10 | Agilent Technologies | 46.99 Bn | 39.88 Bn | 1.04 Bn | 1.76 Bn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.10 Bn |
| Mar 31, 2026 | 6.80 Bn |
| Dec 31, 2025 | 8.52 Bn |
| Sep 30, 2025 | 7.51 Bn |
| Jun 30, 2025 | 6.95 Bn |
| Mar 31, 2025 | 6.53 Bn |
| Dec 31, 2024 | 7.62 Bn |
| Sep 30, 2024 | 7.56 Bn |
| Jun 30, 2024 | 6.99 Bn |
| Mar 31, 2024 | 6.28 Bn |
| Dec 31, 2023 | 6.90 Bn |
| Sep 30, 2023 | 6.71 Bn |
| Jun 30, 2023 | 7.84 Bn |
| Mar 31, 2023 | 9.16 Bn |
| Dec 31, 2022 | 9.88 Bn |
| Sep 30, 2022 | 9.59 Bn |
| Jun 30, 2022 | 8.94 Bn |
| Mar 31, 2022 | 7.68 Bn |
| Dec 31, 2021 | 9.80 Bn |
| Sep 30, 2021 | 9.30 Bn |
Abbott Laboratories Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ABT&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "ABT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ABT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();